Health

All Health

  • Ending HIV transmission by 2030

    Eradicating the remaining pockets of HIV transmission in the U.S. by 2030 will be a challenge for the Trump administration, and depend on local cooperation in reaching high-risk groups with surveillance, prevention, and treatment, according to Harvard HIV/AIDS researcher Max Essex.

    Max Essex
  • Harnessing nature to beat cancer

    Every year, more than 18 million people around the world are told, “You have cancer.” In the U.S., nearly half of all men and more than one-third of women will…

    Nanoparticles
  • The algorithm will see you now

    AI is coming to a hospital near you — but it may be in the world’s remote regions that it could impact patients most. However, experts gathered at Harvard said its potential will not be realized unless it is deployed as part of broader health care solutions, not simply as a tool in search of problems.

    Ashley Nunes at the podium
  • Medicating mosquitoes to fight malaria

    Considering a new strategy for malaria control that complements existing insecticide-treated bed nets, a Harvard-led study found that mosquitoes landing on surfaces coated with the antimalarial drug atovaquone were blocked from developing the parasite that causes the disease.

    Mosquito net
  • Overlapping surgeries mostly safe

    Overlapping surgeries, in which more than one doctor performs sequential surgeries in different operating rooms, have raised concerns about potential adverse outcomes — but a new analysis shows they carry no greater risk for low-risk, noncardiac patients.

    Surgeons
  • Quitting smoking may reduce risk of rheumatoid arthritis

    Analysis of data from the Nurses’ Health studies shows quitting smoking may reduce the risk of the severest form of rheumatoid arthritis.

    Arthritic hands typing on a keyboard.
  • Gene therapy was a ‘last shot’

    Three years after undergoing gene therapy at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center to treat a life-threatening immune disorder, an Ohio college student is no longer thinking about his own “last shot” for health, but rather about medical school and “giving back.”

    Brenden Whittaker and David Williams
  • Exercise, fasting help cells shed defective proteins

    A new study from the Blavatnik Institute finds that intense exercise and fasting activate hormones that boost cells’ capacity to dispose of defective proteins, which clog up the cell, interfere with its functions, and, over time, precipitate diseases including neurodegenerative conditions such as ALS and Alzheimer’s.

    cells fasting
  • A program to give workforce well-being a boost

    Harvard Chan School of Public Health researchers are engaging with some of the world’s most recognizable brands to improve working conditions and workplace well-being around the world.

    Eileen McNeely.
  • Drop and give me 40

    Harvard researchers have found that the number of pushups middle-aged men can do may be a useful, no-cost tool to help clinicians assess cardiovascular disease risk during routine examinations.

    Man doing pushups
  • Finding our genomic clockwork

    Harvard researchers have discovered that a novel biomarker of aging in rDNA can accurately determine an individual’s chronological and biological age. The biomarker opens new opportunities for monitoring responses to interventions and lifestyle choices.

    Illustration of man's shadow forming hands on a clock.
  • Platelet ‘decoys’ outsmart both clots and cancer

    A team of researchers at the Wyss Institute at Harvard University and several collaborating institutions has created a drug-free, reversible antiplatelet therapy that uses deactivated “decoy” platelets to reduce the risk of blood clots and potentially prevent cancer metastasis.

  • Interaction between immune factors can trigger cancer

    Harvard researchers found that interaction between immune factors triggers cancer-promoting chronic inflammation, setting the stage for the development of skin cancer associated with chronic dermatitis and colorectal cancer in patients with colitis.

    Cancer cells in mouse
  • Engineered mini-kidneys come of age

    By exposing stem cell-derived kidney organoids to fluidic shear stress, A team of Harvard researchers has significantly expanded the organoids’ vascular networks and improved the maturation of kidney compartments.

    Culturing kidney organoids
  • Microneedle pill takes the sting out of insulin

    A team of investigators from Harvard-affiliated Brigham and Women’s Hospital, MIT, and Novo Nordisk has developed a microneedle pill that can deliver an oral formulation of insulin that can be swallowed rather than injected.

    Microneedle.
  • Toward safer bone-marrow transplants

    The combination of the antibody CD117 and the drug saporin selectively targets blood stem cells, making transplantation safer by limiting collateral damage caused by the current standard of treatment, chemotherapy, and radiation.

    hematopoietic stem cells
  • The science, business of aging

    A half-day conference at Harvard Business School examined the growing promise of research on aging and the potential of now-experimental interventions to one day ease the burdens of infirmity.

    A man at a podium with big projection screens on either side of him
  • A gathering to battle cancer

    Amid projections that global cancer rates will skyrocket, researchers from around the country gathered at Harvard Monday to share their latest findings and to launch a center whose aim is to boost cancer early detection and prevention.

  • Spending dips on health care for the Medicare elderly

    Health care spending among the Medicare population age 65 and older has slowed dramatically since 2005, and as much as half of that reduction can be attributed to reduced spending on cardiovascular disease, a new Harvard study has found.

    David Cutler
  • Soldiers’ songs of pain — but also healing

    A project to write songs using individual soldiers’ combat experiences appears to help them overcome haunting memories of war, lessening the impact of trauma held too close for too long.

  • Controversy over e-cigarette flavorings heats up

    A new study finds two chemicals commonly used to flavor e-cigarettes may be damaging cilia production and function in the human airway.

    hand holding an electronic cigarette
  • Epidemic of autoimmune diseases calls for action

    Scientists at the Harvard Stem Cell Institute are seeking ways to protect newly transplanted cells from autoimmune attack.

    Beta cells made from stem cells, as seen under the microscope.
  • Early birds may be happier than night owls

    A new study finds that being genetically programmed to rise early may lead to greater well-being and a lower risk of schizophrenia and depression.

    Harvard men's crew on Charles River
  • The master of survival

    Proteins produced by the tardigrade are suspected of playing a role in the organism’s resilience, ultimately providing the basis for human therapies that halt tissue damage and prevent cell death.

  • Summoning happiness to aid recovery

    Reliving happy memories and anticipating pleasure boosted the moods of people recovering from addiction in a study conducted by researchers at MGH’s Recovery Research Institute who eye such exercises as a potential treatment tool.

    Hand choosing smiley face from jar of emoticons.
  • Financial stress linked to heart disease risk among African-Americans

    In a new study, researchers found that African-Americans who experienced moderate to high financial stress had an increased risk of developing heart disease compared with those who did not report such stress.

    A person getting their blood pressure taken with a cuff
  • Patients and doctors see the upside to virtual video visits

    Study finds virtual video visits, one form of telehealth visit used at MGH, can successfully replace office visits for many patients without compromising the quality of care and communication.

  • ZIP code or genetic code?

    In the largest study of U.S. twins to date, researchers use insurance records to tease out the effects of genes and the environment in 560 diseases.

  • People with Down syndrome never stop learning

    A new study from MassGeneral Hospital for Children looks at how people with Down syndrome continue to learn.

    Little boy with Down syndrome
  • 12-step guide to keeping those resolutions

    Figure out what resolutions fit your lifestyle and then make them happen with some expert advice.

    Resolutions journal